Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S)-2-((2S,8S,11S,14S)-8-((1H-indol-3-yl)methyl)-14,18-diamino-2,11-bis(4-aminobutyl)-5-(anthracen-9-ylmethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecanamido)-6-amino-N-((S)-1-((S)-1-((S)-1,6-diamino-1-oxohexan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)hexanamide
ID: ALA5279489
Max Phase: Preclinical
Molecular Formula: C80H106N18O9
Molecular Weight: 1463.84
Associated Items: